# Prevalence of Amyloidosis in Heart Failure (PREVAMIC)

> **NCT04066452** · — · UNKNOWN · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 450 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DIAGNOSTIC_TEST:** Bone-cardiac scintigraphy with Tc-DPD (or similar: Tc-PYP or Tc-HMDP).
- **DIAGNOSTIC_TEST:** Proteinogram and serum immunoglobulins. Light chains free in serum -Freelite-. Immunofixation in serum and urine

## Key facts

- **NCT ID:** NCT04066452
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-03
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2020-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066452, "Prevalence of Amyloidosis in Heart Failure (PREVAMIC)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04066452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*